U.S. Health Secretary Robert F. Kennedy Jr.'s recent dismissal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) has triggered a strong backlash from vaccine experts. The ousted panelists warn that the abrupt shakeup may undermine public health, reduce access to lifesaving vaccines, and increase the risk of preventable disease outbreaks.
Kennedy, a longtime vaccine skeptic, replaced the committee with eight new appointees, some of whom have publicly questioned vaccine safety. The decision was made just two days after the firings on June 9, 2025. In a joint article published in the Journal of the American Medical Association (JAMA), the former ACIP members expressed alarm over what they described as a destabilizing and unjustified overhaul.
They argue that the move, along with cuts to CDC immunization staff, weakens the national vaccine program and threatens decades of progress. “These decisions, made without clear rationale, may roll back the achievements of U.S. immunization policy,” the experts wrote. They emphasized the potential risk to public trust and the safety of families across the country.
Kennedy claimed the firings were necessary to eliminate alleged conflicts of interest among the previous panel members, many of whom were appointed during the Biden administration. However, he provided no evidence of specific misconduct or bias.
Health professionals and scientists warn that politicizing vaccine oversight could erode confidence in health authorities and negatively impact vaccine uptake. The Department of Health and Human Services has not yet responded to media inquiries regarding the controversy.
Kennedy’s sweeping changes mark a significant shift in U.S. health policy and come amid growing concerns over misinformation and vaccine hesitancy.


Belarus Frees Opposition Leaders Maria Kalesnikava and Viktar Babaryka in U.S.-Brokered Deal
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Bolivia Orders Pre-Trial Detention of Former President Luis Arce Over Embezzlement Probe
Colombia’s Clan del Golfo Peace Talks Signal Mandatory Prison Sentences for Top Leaders
California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee
Australia Pushes Forward on AUKUS Submarine Program Amid Workforce and Production Challenges
Trump Signs Executive Order to Strengthen U.S. Food Supply Chain Security
DOJ Sues Loudoun County School Board Over Transgender Locker Room Policy
Thailand Vows Continued Military Action Amid Cambodia Border Clash Despite Trump Ceasefire Claim
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
U.S.-EU Tensions Rise After $140 Million Fine on Elon Musk’s X Platform
CFPB to Review Anti-Discrimination Policies and Fair Lending Rules Amid Policy Shift
Syria Arrests Five Suspects After Deadly Attack on U.S. and Syrian Troops in Palmyra
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
U.S. Soldiers Killed in ISIS Attack in Palmyra, Syria During Counterterrorism Mission 



